(Health Korea News / Changyong Lee) ‘Pharmaceutical 24 Hours’ is a corner that shows brief news related to pharmaceutical and biotechnology at a glance that is easy to miss. It may seem like trivial news, but it could be valuable information to someone, so we summarize the facts and present them in an easy-to-understand manner.
◆ Dongseong Pharmaceutical participates in the Q10 Megawari event for ‘EZN’
Dongsung Pharmaceutical’s self-hair styling brand ‘eZn’ will participate in Japan’s largest open market platform ‘Qoo10’ Megawari promotion held from November 15th to 27th.
Q10 ‘Megawari’ is a mega discount promotion that Q10 runs once a quarter and four times a year.
Dongseong Pharmaceutical is participating in Q10’s 4th quarter Megawari and plans to showcase ‘EZN’s popular products, Pudding Hair Color and Bleach, as well as hair care line Dr. Bond and gray hair dye Touch Vegan products. This event not only provides a 20% discount on all products, but also provides EasyN treatment products and samples as free gifts to customers who purchase them.
Dongseong Pharmaceutical’s ‘EZN’ is a self-dyeing product that has been loved for a long time, winning first place in the ‘Brand of the Year’ hair dye category for five consecutive years. To celebrate its 10th anniversary this year, EZN is carrying out various marketing activities, including the Birthday Girl campaign with domestic and foreign influencers, as well as outdoor advertising and FOOH advertising campaigns.
◆ Yuyu Pharmaceutical and labor union carry out environmental cleanup volunteer activities
Yuyu Pharmaceutical announced on the 1st that, together with the labor union, it had conducted volunteer work to clean up the environment at Uirimji, a tourist attraction in Jecheon, North Chungcheong Province, where the plant is located.
This environmental cleanup volunteer activity, in which a total of 39 Yuyu Pharmaceutical executives and employees participated, was carried out as part of local social contribution in place of the union member retreat held every year under labor-management agreement.
Yuyu Pharmaceutical Labor Union Chairman Lee Jang-hoon said, “We will continue to carry out various activities to coexist with the North Chungcheong community in the future.”
◆ Health insurance coverage for new paroxysmal nocturnal hemoglobinuria (PNH) treatment ‘Empaveli’
Handok’s new paroxysmal nocturnal hemoglobinuria (PNH) treatment ‘Empaveli (ingredient name: pegcetacoplan)’ will be covered by health insurance starting November 1.
Empaveli is the first C3 protein-targeted therapy for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria. It is attracting attention as the first PNH treatment that can solve both intravascular and extravascular hemolysis, and is being used with approval in many countries, including the United States, Europe, Australia, and Japan. Empaveli is a new drug jointly developed by global biopharmaceutical companies ‘Sobi’ and ‘Apellis’, and has been approved in Korea by Handok.
Empaveli’s salary standard can be used if one of the following two conditions applies: ▲Adult PNH patients who cannot take C5 inhibitors (Eculizumab or Ravulizumab injections) due to contraindications ▲If they have taken C5 inhibitors for more than 3 months but their hemoglobin (Hb) is less than 10.5g/dL or there is a need for replacement due to side effects It’s a case. Unlike existing C5 inhibitors, Empabellinun can be prescribed without prior review.
◆ “Refresh yourself with a family trip” Kwangdong Pharmaceutical realizes work-life balance by supporting healing trips
Kwangdong Pharmaceutical announced on the 1st that it had conducted a ‘Family Healing Travel Campaign’ to support travel expenses for executives and employees.
The ‘Family Healing Travel Campaign’ is an in-house welfare event that helps employees and their families go on a trip for the day or for 2 days and 1 night. Up to 300,000 won per family and travel expenses, including cultural experience entrance fees, are supported.
This campaign was conducted to relieve members’ stress and provide them with an opportunity to recharge. About 20 employees and their families selected through a lottery enjoyed relaxation in nature at domestic travel destinations such as Sejong City and Bonghwa, Gyeongsangbuk-do.
Meanwhile, Kwangdong Pharmaceutical provides ▲5 days of summer leave granted separately in addition to the statutory annual leave ▲Summer vacation condo lodging and vacation expenses ▲’Refresh leave’ using annual leave for 3 to 5 consecutive days on weekdays ▲Airline tickets and lodging expenses for long-term employees We operate a variety of relaxation support programs, including:
◆ UBCare ‘Miso Mall.com’ secures the industry’s largest supply of obesity treatment drug ‘Wegobi’
Misomall.com, an online shopping mall for hospital and clinic medical supplies and medicines of digital healthcare platform company UBCare, announced on the 1st that it has secured a large quantity of obesity treatment drug Wegobi.
Wigobi (ingredient name: semaglutide), an obesity treatment that was officially launched in Korea on October 15th, is a Novo Nordisk obesity treatment developed to be administered once a week for one month (4 weeks) with one pen-shaped injection.
Although it is currently being prescribed by doctors at hospitals and clinics, it is difficult to obtain as it has been sold out immediately after its release as news of its use by celebrities spread along with clinical results showing that it has an excellent weight loss effect. As orders from hospitals, clinics, and pharmacies are flooding in, and distributors are competing to secure supplies, UBCare’s Miso Mall.com has secured the largest volume early compared to its competitors, and will begin selling on the 4th. Wegobee’s third large-scale sale begins.
The targets are three products by dosage, including 0.25 mg, 0.5 mg, and 1.0 mg, and the company announced that it has prepared more than twice the quantity compared to competitors.
◆ Lee Jong-cheol, CEO of Yongma Logis, received the Presidential Citation at the Korea Logistics Awards.
Yongma Logis, a logistics company owned by Dong-A Socio Holdings, announced on the 1st that CEO Jong-cheol Lee received a presidential commendation at the 32nd Korea Logistics Awards ceremony held at the Korea Chamber of Commerce and Industry in Seoul.
The Korea Logistics Awards, hosted by the Korea Integrated Logistics Association and organized by the Korea Integrated Logistics Association and the Korea Chamber of Commerce and Industry, commemorates Logistics Day on November 1st every year to encourage and provide pride for the hard work of logistics professionals who have contributed to the development of the national economy and logistics industry. This is an event designed to increase
CEO Jong-cheol Lee received the award in recognition of his contribution to public health by establishing a pharmaceutical cold chain infrastructure and improving the quality of delivery services, and for his contribution to strengthening the competitiveness of the logistics industry, including job creation.
Pharmaceutical cold chain refers to a management system for safely storing and transporting temperature-sensitive medicines such as vaccines, biological products, and hormones. It is essential to maintain the efficacy and safety of medicines. Yongma Logis has established and operates a stable, constant-temperature logistics system that can maintain the quality of medicines and vaccines throughout the entire logistics process, from warehousing to storage and sorting, trunk transportation, and delivery.
Copyright © Health Korea News Unauthorized reproduction and redistribution prohibited
Source: www.hkn24.com
